SCHEMBL6175674

SCHEMBL6175674

CC1(Cc2ccnc(C(=O)N3CCCCC3)c2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 5/20 0.42
MCHR1 Q99705 1/20 0.36
IGF1R P08069 2/20 0.36
KDM4E B2RXH2 1/20 0.35
AR P10275 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CCR6 P51684 1/20 0.35
SCN9A Q15858 1/20 0.35
MAPK7 Q13164 3/20 0.34
PTGS2 P35354 1/20 0.34
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34
PRKAG2 Q9UGJ0 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
BTK Q06187 1/20 0.34
ITGAL P20701 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173342 0.93 ABL1 (0.40) EPHX2MCHR1IGF1RMAPK7PRKAA2
SCHEMBL6172198 0.92 EPHX2 (0.43) EPHX2MCHR1IGF1RMAPK7
SCHEMBL6173118 0.90 KCNA5 (0.41) EPHX2SCN9AMAPK7
SCHEMBL6177034 0.87 IGF1R (0.40) IGF1RARPPARDPPARAPTGS2
SCHEMBL6175879 0.87 IGF1R (0.51) IGF1R
SCHEMBL6172261 0.84 IGF1R (0.49) EPHX2IGF1RARSCN9APTGS2
SCHEMBL6172594 0.84 AR (0.40) EPHX2IGF1RARPPARDPPARA
SCHEMBL6173978 0.84 CCR6 (0.46) MCHR1ARCCR6SCN9AITGAL
SCHEMBL6171575 0.84 IGF1R (0.40) MCHR1IGF1RARPPARDPPARA
SCHEMBL6173853 0.83 IGF1R (0.37) EPHX2IGF1RARPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed